﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>26</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>02</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Determinants of Left Ventricular Systolic Function One Year after Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction in a Middle-Income Country</ArticleTitle>
    <FirstPage>92</FirstPage>
    <LastPage>99</LastPage>
    <ELocationID EIdType="doi">10.34172/aim.2023.15</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Heidari Moghadam</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0277-1488</Identifier>
      </Author>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Salehi</LastName>
      </Author>
      <Author>
        <FirstName>Susan</FirstName>
        <LastName>Mahmoudi</LastName>
      </Author>
      <Author>
        <FirstName>Lida</FirstName>
        <LastName>Shojaei</LastName>
      </Author>
      <Author>
        <FirstName>Sirus</FirstName>
        <LastName>Nasiri</LastName>
      </Author>
      <Author>
        <FirstName>Soraya</FirstName>
        <LastName>Siabani</LastName>
      </Author>
      <Author>
        <FirstName>Parisa</FirstName>
        <LastName>Janjani</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Rouzbahani</LastName>
      </Author>
      <Author>
        <FirstName>Hooman</FirstName>
        <LastName>Tadbiri</LastName>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Nalini</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7464-9756</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/aim.2023.15</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>03</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>08</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Background: Little is known about the predictors of left ventricular ejection fraction (LVEF) —an important predictor of mortality— after primary percutaneous coronary intervention (PCI) in low- and middle-income countries. Methods: In a prospective cohort study at Imam Ali hospital, Kermanshah, Iran, we enrolled consecutive ST-elevation myocardial infarction (STEMI) patients treated with primary PCI (2016-2018) and followed them up to one year. LVEF levels were measured by echocardiography, at baseline and one-year follow-up. Determinants of preserved/improved LVEF were assessed using multi-variable logistic regression models. Results: Of 803 patients (mean age 58.53±11.7 years, 20.5% women), baseline LVEF levels of ≤35% were reported in 44%, 35- 50% in 40%, and ≥50% in 16% of patients. The mean ± SD of LVEF increased from 38.13%±9.2% at baseline to 41.49%±9.5% at follow-up. LVEF was preserved/improved in 629 (78.3%) patients. Adjusted ORs (95% CIs) for predictors of preserved/improved LVEF showed positive associations with creatinine clearance, 1.01 (1.00-1.02) and adherence to clopidogrel, 2.01 (1.33-3.02); and inverse associations with history of myocardial infarction (MI), 0.44 (0.25-0.78); creatine kinase MB (CK-MB), 0.997 (0.996- 0.999); door-balloon time (3rd vs. 1st tertile), 0.62 (0.39-0.98); number of diseased vessels (2 and 3 vs. 1: 0.63 (0.41-0.99) and 0.58 (0.36-0.93), respectively); and baseline LVEF (35-50% and ≥50% vs. ≤35%: 0.45 (0.28-0.71) and 0.19 (0.11-0.34), respectively). Conclusion: Adherence to clopidogrel, short door-balloon time, high creatinine clearance, and lower baseline LVEF were associated with preserved/improved LVEF, while history of MI, high CK-MB, and multi-vessel disease were predictors of reduced LVEF. Long-term drug adherence should be considered for LVEF improvement in low- and middle-income countries.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cardiovascular disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ejection fraction</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ischemic heart disease</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>